-
Mashup Score: 32
By Allison C. Y. Tso, Wee Joo Chng & 7 more. Positioning daratumumab in earlier lines of therapy leads to better outcomes and may mitigate the impact of high-risk FISH abnormalities.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Delivering an impactful presentation: a practical guide | Published in Clinical Hematology International - 1 month(s) ago
By Mohamad Mohty. Presentations are a powerful and enduring form of communication in the scientific and medical fields.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22Prophylactic Cranial Irradiation prior to HCT for Acute Lymphoblastic Leukemia: To Boost or Not To Boost | Published in Clinical Hematology International - 1 month(s) ago
By Khalid Halahleh, Mohammad S. Makoseh & 9 more. Total body irradiation (TBI) with or without cranial radiation boost (CRB) is an integral component of conditioning prior to allogeneic hematopoietic cell transplantation (allo-HCT) in acute lymphoblastic leukemia (ALL).
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
By Tanvi H. Patel, Ramya Bachu & 13 more. Given anxiety’s detrimental effects, our findings emphasize the importance of incorporating psychosocial assessments to optimize care for MGUS and SMM patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38Articles | Clinical Hematology International - 3 month(s) ago
Open-Access journal published by the International Academy for Clinical Hematology
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 25
By Yoojin Park, Silvia Park & 6 more. Recipients of allo-SCT are at high risk for viral infection due to delayed immune recovery and immune-suppressive therapy.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21
By Olivier Decaux, Ronan Garlantézec & 21 more. Multiple myeloma remains incurable, and management involves cycles of treatment response, disease relapse, and further therapy. Thus, the EMMY study was designed to annually assess the therapeutic management of MM.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23The doctor, the patient, and the computer | Published in Clinical Hematology International - 4 month(s) ago
By Finn Bo Petersen, Mohamad Mohty & 1 more. “the doctor kept looking into the computer screen on their desk during the whole consultation and wasn’t looking at or listening to me”.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27Standing on the Shoulders of the Giants: Dr. Kanti R Rai | Published in Clinical Hematology International - 4 month(s) ago
By Mohamad Mohty, Kanti Rai. Dr Rai is the chief of Northwell Health’s CLL Research and Treatment Program. He is internationally recognized for his expertise in diagnosing and treating leukemia patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32The Evolving Role of Bridging Therapy during CAR-T Therapy | Published in Clinical Hematology International - 4 month(s) ago
By Shakthi T Bhaskar, Bhagirathbhai Dholaria & 2 more. The Evolving Role of Bridging Therapy during CAR-T Therapy
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study Published in Clin Hematol Int, the official peer-reviewed journal of @TheIACH https://t.co/xxE4LwioO2